Startups
PCG
Edit

PCG

https://pcgadvisory.com/
Last activity: 22.09.2026
Active
Categories: AdTechDevelopmentLifeMarketMessangerPlatformPublicScienceServiceTechnology
An integrated digital media and global distribution platform for transformative, emerging-growth companies. http://pcgadvisory.com/disclaimer/
Mentions
57

Mentions in press and media 57

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Aug 29, 2024BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ETAdvanced wound care MedTech company recently reported a record second-quarter with $116.4M in revenue for H1, 2024 POMPANO BEACH, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focu...
Aug 29, 2024BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ETPOMPANO BEACH, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, ...
Aug 3, 2023Aemetis Reports Second Quarter 2023 Financial ResultsIndia Biodiesel Generates Revenues of $33.6 million from Supply to India Oil Marketing Companies CUPERTINO, CA, Aug. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels c...
Mar 31, 2023Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results- Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital ichthyosis, ARCI and XLRI - - Timber has enrolled 50% of patients for pivotal TMB-001 Phase 3 A...
Feb 13, 2023Aemetis Unveils Five Year Plan Targeting $2.0 Billion of Revenue, $496 Million of Net Income and $682 Million of Adjusted EBITDA in 2027CUPERTINO, CA / ACCESSWIRE / February 13, 2023 / Aemetis, Inc. (NASDAQ:AMTX), a leading producer of below zero carbon intensity dairy Renewable Natural Gas and developer of the Carbon Zero renewable jet/diesel biorefineries with carbon sequ...
Dec 17, 2022Argentum 47, Inc. Releases Correction Statement Disclaiming Connection to AppleTV+ and BBC OneWINDSOR, BERKSHIRE, United Kingdom, Dec. 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Argentum 47, Inc. ("Argentum" or the "Company") (www.argq.io) ARGQ, a provider of comprehensive artificial intelligence enhanced di...
Oct 3, 2022John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon AdvisorAclarion Key Opinion Leader program supports focused strategy of building strong clinical evidence and payer community advocacy to drive adoption of NociscanTM solution BROOMFIELD, CO / ACCESSWIRE / October 3, 2022 / Aclarion, Inc., ("...
Aug 26, 2022Craft Capital Management Announces Pricing of Initial Public Offering for PaxMedica, Inc.Shares will Trade on Nasdaq Capital Market under Ticker Symbol "PXMD" TARRYTOWN, NY / ACCESSWIRE / August 26, 2022 / PaxMedica, Inc. (Nasdaq:PXMD), a clinical stage biopharmaceutical company focusing on the development of anti-pur...
Aug 16, 2022Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined RevenuesANN ARBOR, MI / ACCESSWIRE / August 15, 2022 / Zomedica Corp. ZOM ("Zomedica" or "Company, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated f...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about PCG

Is PCG still active?

Yes, PCG is active; its latest activity on Parsers VC dates from Sep 22, 2026.